Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1204742-76-6

Post Buying Request

1204742-76-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1204742-76-6 Usage

Description

Imidazo[1,2-a]pyridine-6-boronic acid pinacol ester is an organic compound that serves as a key intermediate in the synthesis of various biologically active molecules, particularly those with potential applications in the pharmaceutical industry. It is characterized by its unique chemical structure, which includes an imidazo[1,2-a]pyridine core and a boronic acid pinacol ester functional group.

Uses

Used in Pharmaceutical Industry:
Imidazo[1,2-a]pyridine-6-boronic acid pinacol ester is used as a reagent for the preparation of Fatty Acid Synthase (FASN) inhibitors. These inhibitors are valuable in the treatment of various diseases, including cancer, due to their ability to disrupt the synthesis of fatty acids, which are essential for the growth and survival of cancer cells.
The compound's role in the development of FASN inhibitors highlights its potential as a therapeutic agent in the fight against cancer and other diseases. By targeting the fatty acid synthesis pathway, Imidazo[1,2-a]pyridine-6-boronic acid pinacol ester-based inhibitors can help to limit the proliferation of cancer cells and improve the effectiveness of existing treatments.

Check Digit Verification of cas no

The CAS Registry Mumber 1204742-76-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,4,7,4 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1204742-76:
(9*1)+(8*2)+(7*0)+(6*4)+(5*7)+(4*4)+(3*2)+(2*7)+(1*6)=126
126 % 10 = 6
So 1204742-76-6 is a valid CAS Registry Number.

1204742-76-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine

1.2 Other means of identification

Product number -
Other names 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1204742-76-6 SDS

1204742-76-6Downstream Products

1204742-76-6Relevant articles and documents

INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE

-

Paragraph 0506, (2021/09/04)

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

Transition metal complex, polymer, mixture, composition and organic electronic device

-

Paragraph 0240; 0244-0246; 0371; 0375-0377, (2020/05/01)

The invention discloses a transition metal complex, a polymer, a mixture, a composition and an organic electronic device. The transition metal complex has a structural general formula represented by achemical formula (1), and is simple to synthesize, novel in structure, relatively good in stability, long in service life and good in light emitting performance; the compound represented by the chemical formula (1) is convenient for realizing an efficient, high-brightness and high-stability OLED device, and a relatively good material option is provided for full-color display and illumination application.

NOVEL BIARYL DERIVATIVE AND PHARMACEUTICAL USE THEREOF

-

Paragraph 0173, (2021/02/19)

PROBLEM TO BE SOLVED: To provide an agent for preventing and/or treating disease associated with group II mGlu receptor. SOLUTION: The present invention provides a compound of formula (1) or a pharmaceutically acceptable salt thereof (R1, Rsup

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1204742-76-6